Loxitane Im

   
Google
 
Web NewDrugInformation.com

Loxitane Im


Drug - Loxitane Im
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Loxapine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - EQ 50MG BASE/ML
The potency of the active ingredient(s), Loxapine Hydrochloride. May repeat for multiple part products.

Applicant - WATSON LABS
The firm name holding legal responsibility for Loxitane Im. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018039
The FDA assigned number to Loxitane Im. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Loxitane Im. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Loxitane Im was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Loxitane Im. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Loxitane Im is in. Format is RX, OTC, DISCN.

Applicant Full Name - Watson Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Loxitane Im.

Loxitane Im